Abstract CT287: CANOPY-A: A phase III, multicenter, randomized trial evaluating canakinumab versus placebo as adjuvant therapy in patients with completely resected non-small cell lung cancer (NSCLC)
Year: 2020
Type: conference-abstract
Source: Cancer Research
Institutions: University of California, Los Angeles, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Aix-Marseille Université, Yonsei University, Hospital de Câncer de Barretos, National Cancer Centre Japan, The Maria Sklodowska-Curie National Research Institute of Oncology, Shanghai Jiao Tong University, Shanghai Chest Hospital, Hospital Universitario 12 De Octubre, Sarah Cannon, Virginia Cancer Specialists, Heidelberg University, University Hospital Heidelberg, German Center for Lung Research, Novartis (United States), National Taiwan University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3081526323